Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin-Reference-Cited by-同舟云学术

Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin

Published:2023-08 Issue: Volume:232 Page:115402
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Kinne Adam S.,Tillman Erik J.,Abdeen Sanofar J.,Johnson Derrick E.,Parmer Elijah S.,Hurst Jacob P.,de Temple Brittany,Rinker Sherri,Rolph Timothy P.,Bowsher Ronald R.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference26 articles.

1. A novel Fc-FGF21 with improved resistance to proteolysis, increased affinity toward β-Klotho, and enhanced efficacy in mice and cynomolgus monkeys;Stanislaus;Endocrinology,2017

2. AKR-001, an Fc-FGF21 analog, showed sustained pharmacodynamic effects on insulin sensitivity and lipid metabolism in type 2 diabetes patients;Kaufman;Cell Rep. Med.,2020

3. Rationale-based engineering of a potent long-acting FGF21 analog for the treatment of type 2 diabetes;Hecht;Plos One,2012

4. FGF21: An emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases;Tillman;Front Endocrinol.,2020

5. Efruxifermin (EFX) in nonalcoholic steatohepatitis with fibrosis;Harrison,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond;Journal of Hepatology;2024-09

2. Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–Phosphorodiamidate Morpholino Oligomer Conjugates for Drug Development;Journal of Medicinal Chemistry;2024-08-28

3. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies;Chinese Journal of Natural Medicines;2024-08

4. Roles of fibroblast growth factors in the treatment of diabetes;World Journal of Diabetes;2024-03-15